Abstract

Lipid-Specific IgM Bands Contribute To Stratify PML Risk in MS Patients Treated With Natalizumab (P2.245)

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call